Schedule 13G ownership disclosure
KARYOPHARM THERAPEUTICS INC
Security class unavailable · CUSIP: 48576U106
Event date: 2019-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,595,001
- Percent of class
- 7.3200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001306923-20-000011
- Form type
- SC 13G
- Filer
- Karyopharm Therapeutics Inc.
- CIK
- CIK 1503802
- Filed
- Feb 14, 2020
- Reporting period
- Dec 31, 2019
- Description
- Schedule 13G beneficial ownership